The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
出版年份 2017 全文链接
标题
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
作者
关键词
Cell-free DNA, DNA methylation, Serum DNA, Ovarian cancer, Early diagnosis, Screening, Personalized treatment
出版物
Genome Medicine
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-12-20
DOI
10.1186/s13073-017-0500-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA
- (2017) Shicheng Guo et al. NATURE GENETICS
- Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis
- (2016) M Hirsch et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes
- (2016) Qing Kang et al. CLINICAL BIOCHEMISTRY
- Methylated circulating tumor DNA in blood: power in cancer prognosis and response
- (2016) Kristina Warton et al. ENDOCRINE-RELATED CANCER
- Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer
- (2016) Archana R. Simmons et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development
- (2016) Gennady Margolin et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2016) Ian J Jacobs et al. LANCET
- Identification of tissue-specific cell death using methylation patterns of circulating DNA
- (2016) Roni Lehmann-Werman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics
- (2016) Peiyong Jiang et al. TRENDS IN GENETICS
- DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer
- (2016) Andrew E Teschendorff et al. Nature Communications
- Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution
- (2016) Thomas E. Bartlett et al. Nature Communications
- Population Distribution of Lifetime Risk of Ovarian Cancer in the United States
- (2015) C. L. Pearce et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening
- (2015) Usha Menon et al. JOURNAL OF CLINICAL ONCOLOGY
- Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Cell-free DNA Analysis for Noninvasive Examination of Trisomy
- (2015) Mary E. Norton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
- (2015) Kun Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
- (2015) Yuxuan Wang et al. Science Translational Medicine
- HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
- (2015) Andrew E. Teschendorff et al. Genome Medicine
- Correlation of Smoking-Associated DNA Methylation Changes in Buccal Cells With DNA Methylation Changes in Epithelial Cancer
- (2015) Andrew E. Teschendorff et al. JAMA Oncology
- Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women’s Cancers
- (2015) Thomas E. Bartlett et al. PLoS One
- Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
- (2015) Richard B. Lanman et al. PLoS One
- Improved reduced representation bisulfite sequencing for epigenomic profiling of clinical samples
- (2014) Yew Lee et al. BIOLOGICAL PROCEDURES ONLINE
- Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer
- (2014) Mary Jo Fackler et al. CANCER RESEARCH
- Validation of a Real-Time PCR-Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human Plasma
- (2014) N. T. Potter et al. CLINICAL CHEMISTRY
- CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy
- (2014) Aurélie Pelissier et al. GYNECOLOGIC ONCOLOGY
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer
- (2014) Tuulia Vallius et al. TUMOR BIOLOGY
- DNA methylation markers for early detection of women’s cancer: promise and challenges
- (2014) Timo Wittenberger et al. Epigenomics
- Recurrent patterns of DNA methylation in theZNF154,CASP8, andVHLpromoters across a wide spectrum of human solid epithelial tumors and cancer cell lines
- (2013) Francisco Sánchez-Vega et al. Epigenetics
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions
- (2012) A. E. Teschendorff et al. BIOINFORMATICS
- Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation
- (2012) Andrew E Teschendorff et al. Genome Medicine
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
- (2011) D. W. Cramer et al. Cancer Prevention Research
- Effect of Screening on Ovarian Cancer Mortality
- (2011) Saundra S. Buys JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling
- (2011) Hongcang Gu et al. Nature Protocols
- Genome-Scale Screen for DNA Methylation-Based Detection Markers for Ovarian Cancer
- (2011) Mihaela Campan et al. PLoS One
- DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
- (2010) N. Shivapurkar et al. CURRENT MOLECULAR MEDICINE
- Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
- (2009) T. deVos et al. CLINICAL CHEMISTRY
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
- (2009) Usha Menon et al. LANCET ONCOLOGY
- Methylated NEUROD1 Promoter is a Marker for Chemosensitivity in Breast Cancer
- (2008) H. Fiegl et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started